Intellectual Property India Publishes Patent Application for 'RH5-Interacting Protein (RIPR) EGF Domain (RIPR EGF) Antigen-Based Malaria Vaccine' Filed by Oxford University Innovation Limited

MUMBAI, India, Sept. 26 -- Intellectual Property India has published a patent application (202527079871 A) filed by Oxford University Innovation Limited, Oxford, U.K., on Aug. 22, for 'rh5-interacting protein (ripr) egf domain (ripr egf) antigen-based malaria vaccine.'

Inventor(s) include Draper, Simon J; Williams, Barnabas G; and King, Lloyd D W.

The application for the patent was published on Sept. 26, under issue no. 39/2025.

According to the abstract released by the Intellectual Property India: "The present invention relates to antigens, antibodies and vaccines for treatment or prevention of malaria."

The patent application was internationally filed on Jan. 26, 2024, under International application No.PCT/GB2024/050210.

Disclaimer: Curated by HT Syndication.